0,908  0,004  Antineoplastic (lung cancer)
0,886  0,003  Antineoplastic (carcinoma)
0,875  0,005  Antineoplastic (breast cancer)
0,857  0,003  Antineoplastic (squamous cell carcinoma)
0,767  0,007  Antihypercholesterolemic
0,744  0,010  CYP2C9 substrate
0,699  0,005  Antimitotic
0,689  0,005  Antipyretic
0,688  0,019  CYP3A4 substrate
0,667  0,006  Hepatic disorders treatment
0,682  0,026  Caspase 9 stimulant
0,659  0,005  Antineoplastic (multiple myeloma)
0,667  0,017  Antineoplastic (colorectal cancer)
0,653  0,007  Caspase 3 stimulant
0,652  0,017  Antineoplastic (colon cancer)
0,633  0,005  Tubulin antagonist
0,632  0,015  Prostate cancer treatment
0,614  0,004  Liver fibrosis treatment
0,612  0,012  Spasmolytic
0,627  0,028  Transcription factor NF kappa B inhibitor
0,632  0,043  Apoptosis agonist
0,577  0,017  Sensitization
0,561  0,005  P-glycoprotein inhibitor
0,548  0,008  CYP3A4 inhibitor
0,552  0,014  NOS2 expression inhibitor
0,548  0,035  TNF expression inhibitor
0,518  0,006  Hepatoprotectant
0,514  0,018  Antineoplastic (brain cancer)
0,556  0,066  Antiinflammatory
0,494  0,029  Respiratory analeptic
0,472  0,027  Antineoplastic (melanoma)
0,475  0,031  Antineoplastic (ovarian cancer)
0,461  0,018  Antineoplastic (lymphoma)
0,485  0,042  Antileukemic
0,448  0,009  Abortion inducer
0,468  0,033  CYP2C19 inhibitor
0,449  0,023  Chemopreventive
0,419  0,010  Genotoxic
0,461  0,053  Antibacterial
0,431  0,023  Antineoplastic (glioblastoma multiforme)
0,435  0,028  Cytostatic
0,427  0,031  Antineoplastic (glioma)
0,405  0,010  Topoisomerase II inhibitor
0,425  0,033  NOS3 expression inhibitor
0,409  0,017  Antineoplastic (lymphocytic leukemia)
0,415  0,034  Antineoplastic (cervical cancer)
0,401  0,024  Antineoplastic (renal cancer)
0,414  0,036  AR expression inhibitor
0,409  0,037  ICAM1 expression inhibitor
0,404  0,037  Antineoplastic (pancreatic cancer)
0,381  0,038  Antioxidant
0,351  0,014  Pneumotoxic
0,363  0,029  Antineoplastic (small cell lung cancer)
0,370  0,039  Antineoplastic (non-small cell lung cancer)
0,366  0,041  Cytotoxic
0,366  0,045  CTGF expression inhibitor
0,364  0,047  Lipoxygenase inhibitor
0,347  0,040  Proliferative diseases treatment
0,337  0,033  DNA synthesis inhibitor
0,334  0,034  Nitric oxide antagonist
0,316  0,020  Melanin inhibitor
0,337  0,042  Free radical scavenger
0,319  0,026  Antiviral (Influenza)
0,339  0,055  Analeptic
0,317  0,036  Sigma receptor agonist
0,276  0,004  Microtubule formation inhibitor
0,282  0,013  Topoisomerase I inhibitor
0,290  0,021  Neurotrophic factor enhancer
0,313  0,046  Antineoplastic (liver cancer)
0,320  0,054  UGT1A9 substrate
0,323  0,059  CYP1A2 substrate
0,265  0,005  Alpha tubulin antagonist
0,348  0,088  Immunosuppressant
0,308  0,049  Antidiabetic symptomatic
0,281  0,023  Anesthetic
0,324  0,069  Vasodilator, coronary
0,262  0,017  Antiviral (Hepatitis B)
0,300  0,057  DNA damaging
0,256  0,016  Antifungal enhancer
0,268  0,028  Lipocortins synthesis antagonist
0,242  0,005  Antineoplastic alkaloid
0,284  0,048  Carcinogenic
0,240  0,016  ATPase inhibitor
0,262  0,040  VCAM1 expression inhibitor
0,295  0,075  CYP2D6 inhibitor
0,297  0,080  Antineoplastic (endocrine cancer)
0,301  0,085  Apoptosis antagonist
0,285  0,073  CYP2C19 substrate
0,304  0,095  Vasodilator, peripheral
0,258  0,052  Antihypertriglyceridemic
0,250  0,050  Anesthetic general
0,293  0,096  Cholesterol antagonist
0,250  0,055  Antiviral (HIV)
0,202  0,008  Beta tubulin antagonist
0,292  0,100  Calcium channel activator
0,222  0,036  Contraceptive
0,239  0,057  RNA-directed DNA polymerase inhibitor
0,272  0,095  Antifungal
0,196  0,020  Cyclooxygenase 3 inhibitor
0,246  0,071  Vasodilator
0,218  0,047  Antiviral (Hepatitis)
0,261  0,091  Hypoxia-inducible factor 1 alpha inhibitor
0,327  0,160  Antineoplastic (solid tumors)
0,188  0,023  Expectorant
0,263  0,099  CYP2D6 substrate
0,228  0,067  Antiparkinsonian, rigidity relieving
0,250  0,093  Radioprotector
0,180  0,025  Antineoplastic antibiotic
0,245  0,093  UGT2B4 substrate
0,195  0,044  Lipid peroxidase inhibitor
0,228  0,078  Cardiodepressant
0,213  0,064  UGT1A1 substrate
0,190  0,048  Amylase inhibitor
0,198  0,057  Muscle relaxant
0,161  0,022  Antiviral (Influenza B)
0,216  0,080  Peptidyltransferase inhibitor
0,200  0,068  Mutagenic
0,184  0,054  Phobic disorders treatment
0,139  0,014  Antiprotozoal activity enhancer
0,143  0,022  CDC-like kinase 3 inhibitor
0,220  0,099  Antineoplastic (sarcoma)
0,142  0,023  Anabolic
0,192  0,075  UDP-glucuronosyltransferase substrate
0,262  0,146  Histamine release inhibitor
0,169  0,056  Protein kinase stimulant
0,244  0,134  Sodium/bile acid cotransporter inhibitor
0,123  0,018  ATPase (Vacuolar H+) inhibitor
0,180  0,074  LDLR expression enhancer
0,202  0,100  Platelet antagonist
0,187  0,088  Psychostimulant
0,121  0,025  Antiviral (Trachoma)
0,242  0,149  Ulceration
0,107  0,016  Postmenopausal disorders treatment
0,145  0,055  Ca2+-transporting ATPase inhibitor
0,152  0,063  Skeletal muscle relaxant
0,103  0,014  Antitreponemal
0,142  0,053  Anesthetic local
0,137  0,048  DNA intercalator
0,186  0,097  Embryotoxic
0,121  0,033  Antihypermotility
0,188  0,101  Teratogen
0,113  0,029  Antibiotic
0,115  0,032  Topoisomerase II alpha inhibitor
0,087  0,005  Ryanodine receptor antagonist
0,156  0,074  Antiviral (Herpes)
0,160  0,081  UGT2B7 substrate
0,125  0,050  Mucolytic
0,132  0,057  Antitussive
0,144  0,070  Antiparkinsonian, tremor relieving
0,083  0,012  Lipocortins synthesis agonist
0,221  0,153  Antineoplastic (osteosarcoma)
0,178  0,115  Antiprotozoal (Leishmania)
0,105  0,042  SULT1E1 substrate
0,143  0,083  Raynaud's phenomenon treatment
0,098  0,040  Contraceptive male
0,088  0,030  Prokinetic
0,096  0,042  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,172  0,120  Cyclic AMP phosphodiesterase inhibitor
0,145  0,094  Arachidonic acid antagonist
0,063  0,012  Microtubule stabilization
0,091  0,042  Glycine receptor antagonist
0,088  0,040  Keratolytic
0,118  0,069  Alcohol dehydrogenase substrate
0,123  0,078  Antiacne
0,135  0,090  NOS3 expression enhancer
0,076  0,033  Neuropeptide agonist
0,065  0,023  Acetyl-CoA transferase 2 inhibitor
0,226  0,185  Antineoplastic (non-Hodgkin's lymphoma)
0,114  0,074  Alkylator
0,155  0,115  Antirickettsial
0,090  0,051  Transcription factor NF kappa B stimulant
0,129  0,094  Antiviral (Influenza A)
0,113  0,078  Growth stimulant
0,063  0,029  Protein 50S ribosomal subunit inhibitor
0,124  0,092  Acaricide
0,131  0,100  UGT1A3 substrate
0,102  0,071  Choleretic
0,137  0,107  Carcinogenic, group 1
0,156  0,126  Antiulcerative
0,108  0,079  Estrogen antagonist
0,136  0,112  Interleukin 6 antagonist
0,053  0,028  Factor III inhibitor
0,057  0,034  Aldose reductase inhibitor
0,111  0,088  Acetylcholinesterase inhibitor
0,054  0,032  Glucose-6-phosphate translocase inhibitor
0,088  0,068  Breast cancer-resistant protein inhibitor
0,177  0,157  Cardioprotectant
0,028  0,009  Endothelin B receptor antagonist
0,085  0,067  Actinic keratosis treatment
0,052  0,034  Estrogen agonist
0,144  0,126  Antineoplastic (bone cancer)
0,033  0,016  Endothelin receptor antagonist
0,091  0,075  UGT2B11 substrate
0,185  0,169  Bone diseases treatment
0,036  0,022  Estrogen receptor alpha agonist
0,114  0,103  Antineoplastic (uterine cancer)
0,113  0,102  Papain-like protease (SARS coronavirus) inhibitor
0,023  0,012  Corticosteroid-like
0,101  0,090  Acetylcholine muscarinic antagonist
0,091  0,081  Estrogen receptor beta antagonist
0,046  0,036  Dopamine transporter inhibitor
0,135  0,125  Platelet adhesion inhibitor
0,032  0,023  Glucocorticoid antagonist
0,047  0,038  Topoisomerase II beta inhibitor
0,030  0,021  RNA-directed RNA polymerase stimulant
0,126  0,119  Antipruritic, non-allergic
0,020  0,015  Endothelin A receptor antagonist
0,117  0,113  Acetylcholine M1 receptor antagonist
0,201  0,197  GST M1-1 substrate
0,062  0,061  Hypercalcemia treatment

